NE
Neuca S.a.
NEU.WA · WSE
699.00 zł +1.90% (+13.00 zł)
1M -9.56%
Market Cap 3.16B zł
P/E Ratio 16.09x
Div. Yield 2.55%
ROE 18.10%
Bulios Fair Price
702.3 zł
0.5% upside
Current Price
699 zł
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NEU.WA is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
76 /100
Cheap P/E 16.09x
EV/EBITDA 8.92x
P/S 0.22x
Growth
55 /100
Stable EPS growth 4.31%
Rev. growth 6.70%
FCF growth 13.46%
Profitability
12 /100
Weak Gross margin 11.62%
Net margin 1.39%
Op. margin 2.11%
Quality
69 /100
Excellent ROIC 10.74%
ROE 18.10%
ROA 3.16%
Debt
61 /100
Moderate Debt/Equity 0.71x
Current ratio 0.89x
Int. coverage 4.44x
Stability
91 /100
Stable Beta 0.46x
Rev. volatility 1.51%
EPS volatility 4.09%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NEU.WA
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Grzegorz Dzik
Employees
5,004
Headquarters
Torun
Upcoming events
19 NOV
Earnings
Upcoming earnings report